Literature DB >> 30459152

LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization.

Ji Cao1, Rong Dong1,2, Li Jiang1, Yanling Gong1, Meng Yuan1, Jieqiong You1, Wen Meng2, Zhanlei Chen3, Ning Zhang4, Qinjie Weng1, Hong Zhu1, Qiaojun He1, Meidan Ying5, Bo Yang5.   

Abstract

M2 polarization of macrophages is essential for their function in immunologic tolerance, which might promote tumorigenesis. However, the molecular mechanism behind the polarization process is not fully understood. Given that several lines of evidence have suggested that long noncoding RNAs (lncRNAs) could be involved in regulating immune cell differentiation and function, the current study aimed to identify the lncRNAs that specifically modulate M2 macrophage polarization. By utilizing a series of cell-based M2 macrophage polarization models, a total of 25 lncRNAs with altered expression were documented based on lncRNA microarray-based profiling assays. Among them, lncRNA-MM2P was the only lncRNA upregulated during M2 polarization but downregulated in M1 macrophages. Knockdown of lncRNA-MM2P blocked cytokine-driven M2 polarization of macrophages and weakened the angiogenesis-promoting feature of M2 macrophages by reducing phosphorylation on STAT6. Moreover, manipulating lncRNA-MM2P in macrophages impaired macrophage-mediated promotion of tumorigenesis, tumor growth in vivo, and tumor angiogenesis. Collectively, our study identifies lncRNA-MM2P as a modulator required for macrophage M2 polarization and uncovers its role in macrophage-promoted tumorigenesis. ©2018 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30459152     DOI: 10.1158/2326-6066.CIR-18-0145

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  48 in total

Review 1.  LncRNA: A Potential Research Direction in Intestinal Barrier Function.

Authors:  Zhi-Feng Jiang; Lin Zhang
Journal:  Dig Dis Sci       Date:  2020-06-26       Impact factor: 3.199

Review 2.  Long noncoding RNAs, emerging and versatile regulators of tumor-induced angiogenesis.

Authors:  Jing Zhao; Li Li; Zhong-Ying Han; Zheng-Xin Wang; Lun-Xiu Qin
Journal:  Am J Cancer Res       Date:  2019-07-01       Impact factor: 6.166

Review 3.  Tumor immune microenvironment lncRNAs.

Authors:  Eun-Gyeong Park; Sung-Jin Pyo; Youxi Cui; Sang-Ho Yoon; Jin-Wu Nam
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

Review 4.  Exosomal non-coding RNAs: Emerging roles in bilateral communication between cancer cells and macrophages.

Authors:  Wenhao Li; Xiaolong Wang; Chen Li; Tong Chen; Qifeng Yang
Journal:  Mol Ther       Date:  2021-12-02       Impact factor: 11.454

Review 5.  Neuroimmune interactions and immunoengineering strategies in peripheral nerve repair.

Authors:  Kathryn L Wofford; Robert B Shultz; Justin C Burrell; D Kacy Cullen
Journal:  Prog Neurobiol       Date:  2021-09-04       Impact factor: 11.685

6.  A Novel lncRNA Panel for Risk Stratification and Immune Landscape in Breast Cancer Patients.

Authors:  Chen Li; Xiaolong Wang; Tong Chen; Wenhao Li; Qifeng Yang
Journal:  Int J Gen Med       Date:  2022-05-27

7.  Construction and validation of an eight pyroptosis-related lncRNA risk model for breast cancer.

Authors:  Miduo Tan; Guo Huang; Jingjing Chen; Jiansheng Yi; Xi Liu; Ni Liao; Yi Hu; Wei Zhou; Qiong Guo
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

Review 8.  Roles of long noncoding RNAs on tumor immune escape by regulating immune cells differentiation and function.

Authors:  Lisha Chang; Juan Li; Jie Ding; Yifan Lian; Chaonan Huangfu; Keming Wang
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

Review 9.  Macrophage Polarization in Response to Biomaterials for Vascularization.

Authors:  Yuqing Wang; Yubo Fan; Haifeng Liu
Journal:  Ann Biomed Eng       Date:  2021-07-19       Impact factor: 3.934

Review 10.  Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.

Authors:  Ya-Nan Pi; Wen-Cai Qi; Bai-Rong Xia; Ge Lou; Wei-Lin Jin
Journal:  Front Immunol       Date:  2021-07-06       Impact factor: 8.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.